MONTEFIORE MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.montefiore.org
A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma
Phase 2
Completed
- Conditions
- Uterine Cancer
- Interventions
- First Posted Date
- 2005-10-04
- Last Posted Date
- 2020-08-12
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 81
- Registration Number
- NCT00231868
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers
Phase 2
Completed
- Conditions
- Ovarian NeoplasmsUterine Neoplasms
- First Posted Date
- 2005-10-04
- Last Posted Date
- 2012-04-24
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 31
- Registration Number
- NCT00231855
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
Divalproex Sodium vs. Placebo in Childhood/Adolescent Autism
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 27
- Registration Number
- NCT00211757
- Locations
- 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States
Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder
Phase 4
Completed
- Conditions
- Obsessive-compulsive Disorder
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2018-05-30
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT00211744
- Locations
- 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States
Divalproex Sodium ER in Adult Autism
Phase 4
Completed
- Conditions
- Autism
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2018-05-31
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT00211796
- Locations
- 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States
Safety and Efficacy Study of Hydromorphone and Morphine
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2018-08-15
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 198
- Registration Number
- NCT00195910
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
OSI-774 (Erlotinib, Tarceva) in Elderly Patients
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2019-12-30
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT00200395
- Locations
- 🇺🇸
Beth Israel Medical Center, New York, New York, United States
🇺🇸New York University, New York, New York, United States
🇺🇸Albert Einstein Cancer Center, Bronx, New York, United States
Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-based Regimen
Completed
- Conditions
- HIV Infection
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2009-11-05
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 90
- Registration Number
- NCT00200369
- Locations
- 🇺🇸
Montefiore Medical Center I.D. Clinic, Bronx, New York, United States
Molecular and Genomic Profiling of Head and Neck Tumors
Recruiting
- Conditions
- Head and Neck Neoplasms
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2025-03-04
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 1000
- Registration Number
- NCT00200486
- Locations
- 🇺🇸
Stelby Augustine, Bronx, New York, United States
Assessment of Early Genetic Changes in Smokers
Terminated
- Conditions
- Cancer of Head and NeckSmoking
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2015-04-08
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT00200408
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
© Copyright 2025. All Rights Reserved by MedPath